Wockhardt's Antibiotic for CABP Gets CDSCO Recommendation
October 11, 2024 18:48
Wockhardt receives a favourable recommendation from CDSCO for its novel antibiotic, Miqnaf, designed for treating community-acquired bacterial pneumonia (CABP) in adults.